Meckel, Marian; Pfannkuchen, Nina; Miederer, Matthias et al.
A DOTA based bisphosphonate containing an albumin binding moiety for delayed body clearance in bone targeting radiotherapyJOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. Bd. 58. 2015 S. S115-S115
Meckel, M.; Bergmann, R.; Mohnike, W. et al.
A DOTA conjugated Zoledronic acid derivative: A novel bone targeting theranostic compoundEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. Bd. 42. 2015 S. S58-S59
Meckel, M.; Pfannkuchen, N.; Miederer, M. et al.
A DOTA-based bisphosphonate with an albumin-binding moiety for delayed body clearance in bone-targeting radiotherapyJOURNAL OF NUCLEAR MEDICINE. Bd. 56. 2015
Meckel, M.; Pfannkuchen, N.; Miederer, M. et al.
A DOTA-zoledronate conjugate for PET diagnosis and endoradiotherapy of bone metastasesJOURNAL OF NUCLEAR MEDICINE. Bd. 56. 2015
Meckel, Marian; Pfannkuchen, Nina; Miederer, Matthias et al.
A DOTA-Zoledronate conjugate for PET-diagnosis and endoradiotherapy of bone metastasesJOURNAL OF NUCLEAR MEDICINE. Bd. 56. H. 3. 2015
Meckel, Marian; Pfannkuchen, Nina; Miederer, Matthias et al.
A DOTA-zoledronate conjugate for PET-diagnosis and endoradiotherapy of bone metastasesJOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. Bd. 58. 2015 S. S50-S50
Dittmar, M.; Reber, H.; Kahaly, G. J.
Bioimpedance phase angle indicates catabolism in Type 2 diabetesDIABETIC MEDICINE. Bd. 32. H. 9. 2015 S. 1177-1185
Deserno, Lorenz; Beck, Anne; Huys, Quentin J. M. et al.
Chronic alcohol intake abolishes the relationship between dopamine synthesis capacity and learning signals in the ventral striatumEUROPEAN JOURNAL OF NEUROSCIENCE. Bd. 41. H. 4. 2015 S. 477-486
Buchholz, Hans-Georg; Wenzel, Fabian; Gartenschläger, Martin et al.
Construction and comparative evaluation of different activity detection methods in brain FDG-PETBiomedical engineering online. Bd. 14. London: BioMed Central 2015 Art. 79
Meckel, Marian; Pfannkuchen, Nina; Miederer, Matthias et al.
DOTA based bisphosphonate with an albumin binding moiety for delayed body clearance in bone targeting radiotherapy: a new class of "DOTA-BPretard" tracersJOURNAL OF NUCLEAR MEDICINE. Bd. 56. H. 3. 2015